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ABSTRACT
Alternative splicing is thought to be one of the major
sources for functional diversity in higher eukaryotes.
Interestingly, when mapping splicing events onto
protein structures, about half of the events affect
structured and even highly conserved regions
i.e. are non-trivial on the structure level. This has
led to the controversial hypothesis that such splice
variants result in nonsense-mediated mRNA decay
or non-functional, unstructured proteins, which do
not contribute to the functional diversity of an
organism. Here we show in a comprehensive
study on alternative splicing that proteins appear
to be much more tolerant to structural deletions,
insertions and replacements than previously
thought. We find literature evidence that such non-
trivial splicing isoforms exhibit different functional
properties compared to their native counterparts
and allow for interesting regulatory patterns on the
protein network level. We provide examples that
splicing events may represent transitions between
different folds in the protein sequence–structure
space and explain these links by a common genetic
mechanism. Taken together, those findings hint to a
more prominent role of splicing in protein structure
evolution and to a different view of phenotypic
plasticity of protein structures.
INTRODUCTION
Alternative splicing is one of the major sources for
functional diversity in the proteomes of multicellular
organisms. It refers to assembling the exons of a gene in
diﬀerent ways during pre-mRNA splicing such that
diﬀerent mRNAs and, thus, proteins are produced from
the same gene. Based on EST data it is estimated that up
to 74% of all human multi-exon genes are alternatively
spliced (1) which drastically increases the number of
proteins in the human proteome and, together with time
and tissue-speciﬁc regulation of alternative splicing,
largely increases the functional complexity of an organ-
ism. Alternatively spliced proteins are involved in many
biological processes such as apoptosis (2) or the control of
synaptic function (3) and play important roles in human
diseases like cancer where the inﬂuence of alternatively
spliced genes on transcription factors of signalling path-
ways have been described (4). The eﬀects of alternative
splicing on the function of a single protein range from
changes in substrate or interaction partner speciﬁcity to
the regulation of DNA-binding properties (5). In order to
change the function of a protein by alternative splicing, its
structure may be changed accordingly.
To date, the structures of less than 10 isoforms are
available in the Protein Data Bank (PDB) (6) and known
structural implications of splicing events on some of those
proteins have been reviewed in Ref. 5. Those examples
include a protein called Piccolo and the surprisingly
drastic rearrangement of its C2-domain altered by a short
insert of nine residues (7). Despite those few examples,
only little is known from experimental data about
how and to what extent alternative splicing aﬀects protein
structures. Due to this lack of knowledge from biological
data, several recent studies (8–10) have mapped alternative
splicing events onto predicted protein structures and
have analysed features of the regions being aﬀected.
While they could link some structural properties like
protein disorder (8) to a group of splicing events, the
eﬀects on many isoforms appear to be non-trivial. Based
on this surprising complexity of alternative splicing on
the proteome level, the most recent study by Tress et al. (9)
even comes to the converse conclusion that ‘it seems
unlikely that the spectrum of conventional enzymatic or
structural functions can be substantially extended through
alternative splicing’.
In this article, we present the results from comprehen-
sively mapping all splice variants annotated in Swissprot
(11) onto known protein structures from the PDB leading
to almost 500 isoforms annotated to more than 350
Swissprot entries whose structures can be modelled with a
very high accuracy (see Materials and Methods section).
While about half of the events fall into variable regions
of protein structures or aﬀect complete domains, the
eﬀects on the other half appear to be non-trivial since
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corresponding protein family. The large number of such
non-trivial events, which are also found to be conserved
among diﬀerent species, can be explained in two ways:
First, non-trivial splicing events are non-functional on
the mRNA or protein level leading to nonsense-mediated
mRNA decay or unstructured proteins that are degraded
after translation. This would indeed allow only few exons
of an organism to be alternatively spliced, clearly ques-
tioning the importance of splicing on the proteome level.
Second, they may represent evidence that non-trivial
splice events may produce functional isoforms where the
absence of highly conserved parts of the structure might
even allow for new structural and new functional proper-
ties of the isoform.
Here we provide evidence for the second hypothesis.
Having mapped a large set of splicing events onto protein
structures, we ﬁrst explore the natural variation of the
corresponding protein structure family, namely the ‘evolu-
tionary isoforms’ of the respective protein, which allow us
to explain 50% of the splicing events. The other half of
the isoforms deﬁnes the set of non-trivial splicing events
which cannot be explained by the observed amount of
variation in the respective protein family and which we
examined in more detail.
Based on evolutionary considerations of known fold-
changing events (12), we group non-trivial events into
eight diﬀerent categories comprising diﬀerent eﬀects to be
expected on the structure level. We then show that an
extensive search of the biological literature provides clear
evidence of stable protein products originating from such
isoforms as well as evidence for a well-deﬁned functional
role of those proteins in the cell. The existence of such
isoforms will help to sharpen our understanding of a
protein’s tolerance against major structural changes and,
additionally, largely increases the importance of alter-
native splicing for generating functional and structural
diversity. We will therefore review the function as well as
the structural complexity of some of those isoforms.
Based on those ﬁndings, we try to explain the tolerance
of such isoforms against the splicing events, which cannot
be explained in their own fold, by members from diﬀerent
folds. We ﬁnd evidence that such links between diﬀerent
folds in the sequence–structure space may indeed exist,
and, for the ﬁrst time, suggest a simple and common
genetic mechanism, namely alternative splicing, for nature
to explore them in vivo. Finally, we show that new
experimental methods like Aﬀymetrix exon array chips
provide interesting data to prove or falsify our hypothesis
in the future.
MATERIALS AND METHODS
In the following, the methods and data sources used for
our study are described in detail. The methods are
summarized in the Supplementary Figure S2.
Alternative splicing and literature data
The data for alternatively spliced proteins used in this
work was obtained from the Swissprot protein database
(September 2006), which annotates splicing events for
9135 out of 231434 protein entries. Those 9135 entries
harbour 20845 alternative splicing events where 56.6% of
the events are deletion events and the other 43.3% of the
events represent replacements. In 22.2% of the replace-
ments, the original sequence is shorter than the replace-
ment sequence (insertions); in 27.7%, the replacement
sequence is shorter than the original sequence (deletions)
while in 50.1% of the cases the original sequence and the
replacement sequence are of the same length. Literature
assignments to diﬀerent isoforms are also provided by
Swissprot. We have examined them manually for evidence
for the experimental proof of a stable protein product as
well as experimental validation of its function.
Proteinstructure assignment
To obtain protein structure data we ran BLAST (13)
against all proteins in the PDB (August 2006) for all
Swissprotproteinswithannotatedsplicingevents.Foreach
alternatively spliced protein, we then used free-shift
alignment (14) (Pam250 matrix, gap open: 12, gap
extend: 1) to compute full-length sequence–structure
alignments of the alternatively spliced Swissprot entries
with their respective homologues identiﬁed by BLAST.
From all alternatively spliced Swissprot proteins, only
those whose structure could be modelled with a very high
sequence identity of at least 60% between template and
target and whose sequence is covered to at least 75% by
protein structure are used for further analysis.
Assignment ofprotein structuresto families
The protein structures used to model the Swissprot
proteins have been assigned to their corresponding
SCOP (15) families as deﬁned in SCOP version 1.71
(December 2006). All Swissprot entries that are modelled
with structures not yet classiﬁed in the SCOP version 1.71
were assigned to their respective protein families using
Vorolign (16). The ﬁnal dataset contains 367 Swissprot
proteins with 488 annotated isoforms, which are classiﬁed
into 166 diﬀerent families, 134 superfamilies and 119 folds
with respect to the SCOP hierarchy.
Multiple structure alignments and evolutionary ‘isoforms’
Multiple structure alignments were computed from multi-
ple structure superpositions with STACCATO (17), which
has been shown to compute accurate alignments with
respect to both, sequence and structure. In order to
guarantee enough variability within the set of evolution-
ary related protein structures, we use proteins from the
same SCOP superfamily. On this level of the SCOP
hierarchy, protein structures exhibit enough structural
variance to allow the deﬁnition of conserved and variable
regions without overestimating structure conservation due
to too similar proteins. Each set must contain at least
three members and their structural similarity is measured
by the TM-Score (18). Proteins in a set have to be similar
enough (indicated by a pairwise TM-Score of >0.4) while
still showing structural variability (TM-Score <0.8).
Given a multiple structure alignment, a ‘conserved
region’ of a SCOP superfamily is deﬁned as a block of at
least 10 residues, which are conserved among all members
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two gaps at most to account for some small variability
within blocks. All regions outside of the conserved blocks
are deﬁned as ‘variable regions’. The proteins in the set
deﬁne what we call ‘evolutionary isoforms’ which display
insertions, deletions and substitutions and deﬁne the set
of evolutionary events that are likely to be tolerable for a
protein structure.
Alternative splicing andalternative structural models
In order to suggest alternative structures for non-trivial
alternative splicing isoforms we applied the splicing event
onto the structure (e.g. removed the structural parts
belonging to a skipped exon). We then searched for
reliable structural superpositions of the resulting structure
model against all known folds (according to the SCOP
classiﬁcation). Such a search resulted in a number of
structurally similar proteins from SCOP folds diﬀerent
than the proteins own fold. The soundness of such
superpositions was measured by diﬀerent criteria. First,
as argued by Zhang and Skolnick (19) a TM-Score >0.4 is
a clear evidence for a structural similarity (criterion 1).
Since we believe this criterion is not strict enough to claim
such remote structural similarities we also used more
stringent criteria. Therefore, we ﬁltered the superpositions
to those superposing at least 80% of the spliced structure
and 60% of its secondary structure elements and
additionally examined the resulting superpositions manu-
ally for the conservation of core secondary structure
elements with the correct connectivity and topology
(criterion 2).
RESULTS
Our study is based on 367 Swissprot proteins and 488
additional splicing isoforms, which can be modelled on the
structure level with a very high accuracy. The ENCODE
dataset analysed in Ref. (9) contains 6 of these proteins
(with 11 isoforms annotated in Swissprot) which are
discussed in the Supplementary Data. As shown in
Figure 1, 50% of the events fall into variable, often
terminal, regions of the corresponding protein superfamily
(evolutionary ‘isoforms’) or aﬀect complete domains.
The other half (255) of the events are harder to explain
since they aﬀect regions conserved in all superfamily
members including core secondary-structure elements as
well as highly conserved residues.
Different categories of non-trivial splicing events
Based on evolutionary considerations about possibly
fold-changing events (12), we deﬁned eight categories
describing diﬀerent types of those splicing events. Due
to their hydrogen-bonding patterns, b-strands being
located at the edge of a larger b-sheet are known to be
more variable than internal b-strands. Therefore, two
categories describe events aﬀecting peripheral or internal
b-strands. Similarly, in proteins belonging to ab-fold
classes, often ab-secondary structure motifs tend to
be aﬀected and, accordingly, we deﬁned two classes
comprising peripheral and internal ab-motifs. Additional
categories contain conserved coil regions, conserved
helices, large-scale events (aﬀecting more than 50% of
the structure) as well as events aﬀecting repetitive protein-
structure families whose repeat number is known to vary
in evolution. Table 1 shows the distribution of the splicing
events in the diﬀerent categories.
Literature search for experimentally verified
and functionally characterized isoforms
The biological literature annotated to the isoforms in
Swissprot provides a valuable source of information.
While Swissprot annotates proteins only if they have been
veriﬁed experimentally, this must not be the case for
their corresponding isoforms that may originate from
Table 1. The distribution of non-trivial isoforms in the eight categories deﬁned based on evolutionary considerations with respect to diﬀerent features
Coil ab (p) b (i) ab (p) ab (i) Repeat Large Total
Conserved region aﬀected (class) 14 50 29 25 49 35 21 37 255
Isoform conﬁrmed (protein level) 4 15 2 9 6 3 1 3 43
Function described 2 7 1 5 5 3 1 2 26
Log Odds: Function/Class 0.36 0.41 1.16 0.78 0 0.2 0.81 0.67
(p) and (i) indicate the position of the corresponding b-strands either at internal or peripheral positions of the sheet. The ‘Conserved region aﬀected’
row displays the number isoforms which aﬀect conserved regions of the corresponding superfamily. The ‘Isoform conﬁrmed’ row displays isoforms
which have been conﬁrmed in the literature (see Supplementary Data for complete list) on the protein level, while the ‘Function described’ row
references isoforms in the diﬀerent categories which have been described in the literature to perform a well-deﬁned function. The ‘Function/Class’
row contains the log odd ratios of functionally described isoforms in the diﬀerent structural classes (third row) versus the background class
distribution (ﬁrst row). All log odd ratios of the values given for ‘Isoform conﬁrmed’ and ‘Function described’ against the background distribution of
structural classes within isoforms with ‘conserved regions aﬀected’ can be found in the Supplementary Data, Figure S1.
Coarse categories of splicing events falling into variable or 
conserved regions
Variable, 173, 
35%
Domain, 55, 11% Large, 37, 8%
Conserved, 223, 
46%
Figure 1. Distribution of 488 splicing events in the four major
categories. 35% of the events fall into variable regions of the
corresponding superfamily while 11% aﬀect complete domains of
multi-domain proteins; 8% of the isoforms aﬀect larger regions (more
than 50% of the structure) while 46% aﬀect conserved regions of their
corresponding superfamily which are present in all superfamily
members.
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isoforms have only been experimentally veriﬁed on the
mRNA level, while the protein products of the isoform
were not investigated in the corresponding study.
Nevertheless, out of the 255 non-trivial isoforms,
43 (17%) have been experimentally validated on the
protein level and for 26 isoforms (10%), the function of
the spliced variant has been described. Surprisingly, and in
contrast to previous ﬁndings, we ﬁnd literature evidence
for functionally important and well-characterized iso-
forms in all of our eight categories (Table 1) indicating
that even large-scale events may lead to functional and
interesting protein products. A complete list of all
literature references and isoforms is given in the
Supplementary Data. In the following, we will review
some interesting isoforms from diﬀerent categories.
Alternative splicing of aterminalregion of aprotein
Many splicing events in our dataset change amino- or
carboxy-terminal parts of a protein structure, which are
found to be more variable and diﬀer signiﬁcantly among
the members of a protein family. One of the examples,
where the splicing event can be explained by the variability
observed in the corresponding protein family is found in
the human protein p38a (Q16539), a member of the
mitogen-activated kinase (MAPK) family. Those proteins
are integral parts of several signal transduction pathways
and known to play important roles e.g. in the stress
response of the cell. For p38a, several splice variants are
annotated in public databases and among the well-studied
splice variants are two proteins known as Mxi2
(Q16539-3) and Exip (Q16539-4) which both diﬀer in
large parts of their carboxy-terminal ends compared to
p38a. Also, a similar splicing event is annotated for a
homologous protein in mouse (P47811-2). The splicing
event annotated for Exip (20) removes 46 residues from
the protein structure, in addition, 52 residues diﬀer in
their sequence due to a frameshift introduced by the event
(Figure 2a). It results in the loss of a well-conserved
interaction domain used to interact with upstream kinases
and downstream substrates. This leads to the fact that the
protein is not targeted by MKK6 anymore. Expression of
the isoform in the cell leads to an earlier onset of apoptosis
and seems to target signal transduction pathways that are
diﬀerent from those targeted by p38a (20). In the example
of Exip, the splicing event indeed targets a more variable
part of the protein family (SCOP superfamily d.144.1).
Structures, which lack the carboxy-terminal part are
known to fold into stable conformations.
Alternative splicing atthe edgesof b-sheets
Alternative splicing events that involve b-strands naturally
lead to the disruption of important hydrogen bonds in
the protein structure. Nevertheless, such events are typical
in the evolution of globular proteins if they aﬀect
peripheral b-strands of a larger b-sheet (12). Therefore,
these events might be tolerable by a protein structure,
even if they aﬀect conserved regions of the protein’s
family. One such event is the removal of one peripheral
ab-motif from LMPTP (P24666), a tyrosine phosphatase.
Figure 2. Visualization of alternative splicing events on the structure level. Substitutions are coloured in green while deletions are coloured in red.
All ﬁgures have been created using PyMOL (http://www.pymol.org). (a) The removal of the carboxy-terminal part from MK14_HUMAN (Q16539-4,
pdb: 1zzlA), (b) the removal of one external strand and helix motif in PPAC_HUMAN (P24666-3, pdb: 5pnt), (c) the removal of an internal strand
in TF65-HUMAN (Q04206-3, pdb 1nﬁ), (d) the removal of a large part of the protein from TIP30_HUMAN (Q9BUP3-2, pdb: 2bkaA), (e) the
removal of several strands in CASP9_HUMAN (P55211-2, pdb: 1nw9B), (f) and (g) the removal of repetitive motifs from WDR1_CAEEL
(Q11176-2: pdb: 1pevA) and CD2A1_HUMAN (P42771-2, pdb 2a5e) as well as (h) the removal of one half of a TIM-barrel structure in
CHIA_HUMAN (Q9BZP6-3, pdb: 1vf8A). A comprehensive database of alternative splicing events mapped onto protein structures can be found at:
http://www.bio.iﬁ.lmu.de/ProSAS/NARSupplement.html.
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isoforms, all of which diﬀer in a 38-amino acid long part
corresponding to one ab-motif. The b-strand represents a
peripheral strand of a b-sheet consisting of four strands in
total. While the original sequence is replaced by another
38 residues in isoform 2, the corresponding part is
removed in isoform 3 (LMPTP-C, P24666-3) (see also
Figure 2b). Detailed analysis of LMPTP-C (21) shows that
the protein is lacking phosphatase activity and can also
not be phosphorylated by Lck kinase indicating that
the active center has been tackled by the splicing event.
When being co-expressed with isoform 2, LMPTP-C
is shown to act as an antagonist to its native variant.
The proposed mechanism (21) is that LMPTP-C competi-
tively associates with the cellular substrates or regulators
of its native counterparts and thereby blocks depho-
sphorylation of their targets. LMPTP-C represents an
example how a splicing event changes a protein’s function
by removing the active center of the protein. While
this goes hand in hand with a loss of its native function,
the isoform is still able to mimic features of the native
structure which allows it to act as antagonist of LMPTP.
Alternative splicing ofinternal strands ofb-sheets
As shown above, the deletion of peripheral ab-motif can
result in a functional protein revealing an interesting
mechanism for the regulation of enzyme activity.
The deletion of internal strands from a b-sheet or a
b-barrel appears to be more problematic since this
results in the loss of hydrogen bonds on both sides of
the strand and requires the formation of several new ones
to retain the native-like structure of the protein.
Nevertheless, there are known examples for strand
deletion events that occurred in structure evolution as
discussed in (12). The p65 (Q04206) subunit of the NF–kB
transcriptional activator has one splice variant
(Q04206-3), which exhibits such a removal event (22) as
shown in Figure 2c, where nine residues, corresponding to
one internal b-strand, are removed. Again, for a homo-
logous protein in mouse (Q04207-2) the same splicing
event is annotated. While the splice variant lost its
capability to bind to p50, the second subunit of the NF–
kB complex, it can form weak heterodimers with the
native isoform of p65. Those heterodimers are found to be
greatly reduced in their ability to bind DNA. This ﬁnding
allows for two possible conclusions. Either, co-expression
of the isoform and the native protein negatively regulates
the NF–kB function, again revealing a pattern where
the inactivation of a protein feature may act as an
antagonist for the native protein. Or, in case that the
isoform is still able to bind IkB (the inhibitor of the NF–
kB complex), it may act as a regulatory ‘sink’ binding
excess IkB and allowing p65 or the p65–p50 complex to
enter the nucleus (22).
Alternative splicing mayaffectlarge and
conservedregions of theprotein structure
In the following, we give evidence for the fact that
alternative splicing events may aﬀect large and conserved
regions of a protein structure and still can result in an
isoform with unique functional features. CC3 (Q9BUP3)
is known to be a metastasis suppressor inducing apoptosis
in human cells, which is not expressed in highly metastatic
lines of ‘small cell lung carcinoma’. A variant, called TC3
(Q9BUP3-2) (23), undergoes an alternative splicing event
which removes 107 residues from its carboxy-terminal
end and further replaces 21 residues at the new terminus
which do not share any sequence similarity with the
original sequence. As shown in Figure 2d, the splicing
event aﬀects more than 50% of the protein structure.
It removes two peripheral b-strands from a b-sheet
consisting of seven strands as well as several additional
helices and strands that are not involved in the formation
of the core aba-fold. Strikingly, TC3 has, in contrast to its
native variant CC3, an anti-apoptotic function that seems
to be located in its unique C-terminal part. Even though
the protein lost several conserved elements of its fold,
it seems to be able to fold into a stable, functional isoform
(see also Figure 3, rightmost column). It is shown to be
short-lived due to a degradation signal located in the new
carboxy-terminal end of the protein (23) that possibly
represents another physiological feature. A second exam-
ple that exhibits a similar splicing event that removes an
even larger part from the structure is an isoform of
caspase 9 (P55211-2) (Figure 2e). The isoform, named
caspase 9b, is again shown to function as an endogenous
apoptosis inhibitory molecule (24). The isoforms of CC3
and caspase 9 reveal a surprising tolerance of aba-fold
proteins to large-scale aberration events. This tolerance
might originate in the evolutionary history of proteins of
this fold class as they might have evolved by successively
adding ab-motifs to the edges of the core sheets. This
might result in the fact that they can also be removed
from the structure without losing capability to fold into a
stable conformation.
Alternative splicing of highly repetitive protein structures
Internal repetition of (super-) secondary structure
elements resulting from intragenic duplication and recom-
bination events has been observed for several protein
structure families. Proteins that exhibit repetitive structure
are involved in many diﬀerent functions in the cell while
an increase of the repeat number in general aﬀords a
protein-enhanced evolutionary prospect due to an enlar-
gement of its binding surface area (25). While repeats are
found in all phyla they seem to be more common in
eukaryotes which may be associated with an increasing
complexity of the cellular functions that are available from
assemblies of repeats. Several protein families contain
repetitive elements but the major classes are b-propellers
(b.67, b.68, b.69, b.70), b-trefoils (SCOP fold b.42), a-a
superhelices (SCOP fold a.118), leucine-rich repeats
(SCOP fold c.10) as well as the b-hairpin-a-hairpin repeats
(SCOP fold d.211) (25). The fact that repeat duplication
has been a successful strategy throughout protein-struc-
ture evolution that changed functional features of the
proteins without losing the possibility to fold into a stable
structure leads to the conclusion that such proteins should
be highly tolerant against structural changes by alternative
splicing. Indeed, we ﬁnd that four out of the ﬁve repeat
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Figure 3. This ﬁgure shows four examples for probable fold-changing events by non-trivial splicing events (i.e. those which cannot be accommodated
in the native structure) identiﬁed by superposing the spliced structure to a diﬀerent SCOP fold. The examples can also be explored interactively
following this link http://www.bio.iﬁ.lmu.de/ProSAS/NARSupplement.html. Each column represents one example. In the ﬁrst row, the splicing event
is visualized on the native protein structure of the Swissprot protein. In the second row, the superposition of the spliced protein with the
corresponding protein from a diﬀerent fold is shown. Rows three and four display TOPS (34) diagrams of the spliced protein (row three) and the
protein belonging to the diﬀerent fold (row four). In the TOPS diagrams, corresponding secondary structure elements are coloured the same,
elements missing in the other protein are coloured in red. Sometimes corresponding helices are split up which frequently results from breaks in the
DSSP assignments. From left to right the following examples are shown: Column 1 DNMT2_HUMAN (O14717-6, Astral: d1g55a_, SCOP:
c.66.1.26). The spliced protein superposes very well (TM-Score: 0.68) with d1gsoa2 (SCOP: c.30.1.1). Topologically the proteins are very similar,
except for a very short strand (length 2) - helix (length 4) motif at the C-terminal end of d1gsoa2. Column 2 AUHM_MOUSE (Q9JLZ3-2, Astral:
d1hzda_, SCOP: c.14.1.3) that superposes well (TM-Score: 0.56) with d1vc1a_ (SCOP: c.13.2.1). Topologically the proteins are similar, except for two
small strands (both of length 2) and one short helix (length 3) missing in d1vc1a_. Additionally, the C-Terminal part of d1vc1a_ has an additional,
short helix-strand motif. Column 3 HER1_CAEEL (P34704-2, Astral: d1szha_, SCOP: a.226.1.1) superposed with d1ni8a_ (SCOP: a.155.1.1, TM-
Score 0.49). Only a small fragment (helix–turn–helix-motif) is left over by the splicing event. The two TOPS diagrams are similar with the two main
helices being preserved while short helical parts are missing in either of the two proteins. Interestingly, d1ni8a_ is described to contribute to DNA
binding after dimerization (35), which might also be the way how the isoform resulting from the HER1 splicing event is stabilized. Column 4
TIP30_HUMAN (Q9BUP3-2, PDB: 2bka, SCOP: c.2.1.2) that again superposes well with d1gsoa2 (see also DNMT2_HUMAN) from SCOP fold
c.30.1.1 (TM-Score: 0.54). Topologically the two proteins are very similar according to TOPS except for two helices missing at the C- and N-terminal
ends. The function of the isoform is discussed in the text (isoform TC3). Images have been created using Jmol (http://www.jmol.org) and PyMol
(http://www.pymol.org).
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alternative splicing events aﬀecting complete sets of
repetitive motifs. Two examples are shown in Figure 2f
and g. For most repetitive protein structures, large-scale
deletion events are likely to be tolerable by the structure
though, unfortunately, experimental validation and a
functional categorization of the splicing variants is missing
for all isoforms in our dataset. The principle of changing
the number of repeats in the course of evolution in order
to evolve novel functional features seems also to be used
frequently to increase the functional diversity by alter-
native splicing as indicated by the large number of
repetitive protein folds with annotated splicing events.
Alternative splicing maysupport hypothesis on
theorigin ofTIM-barrels from half-barrels
For a number of protein structures and protein structure
families it is well known that they resulted from ancient
gene duplication and/or fusion events. Such duplication
events are not always obvious from sequence data since
the two subdomains have possibly already evolved to an
extent where sequence similarity is random. A well-studied
and recurrent motif in protein structures is the (a/b)8-
barrel family (‘TIM-barrel’, SCOP fold c.1). Proteins in
this family adopt a large variety of diﬀerent functions and
based on sequence and structure analysis it has been
proposed (26) for some members of that family that
they originated from a gene duplication and fusion
event of two ancestral half-barrel proteins. Those ancient
half-barrels probably formed a homodimer consisting of
two identical half-barrels (27).
Our analysis now provides additional support for
this hypothesis since it reveals two splicing isoforms
(Q9BZP6-3 from CHIA HUMAN, and P27934-2 from
AMY3E ORYSA) where one half of the barrel is removed
by a large-scale removal event (see Figure 2h). The
isoform of the human chitinase gene (Q9BZP6-3) has
been described by Saito et al. (28) to be speciﬁcally
expressed in lung though experimental validation of the
existence of the stable protein product is lacking. In
comparison to its native isoform, the protein lacks a
secretory signal sequence leading to the conclusion that it
might be present in the cytoplasm instead of being
secreted. It also lacks the amino-terminal active site
essential for chitinase activity. So far, we have no
experimental validation for a functional gene product
and a stable protein resulting from those splicing events.
Nevertheless, based on the proposed evolutionary
mechanism of fusing two half-barrels by an ancient gene
duplication and fusion event, the splicing isoforms
possibly form a (homo-)dimer to reconstruct the complete
barrel. The possibility to express proteins of the TIM-
barrel family as half-barrels might oﬀer an increased
functional variability by combining half-barrels contain-
ing diﬀerent functional sites in heterodimeric complexes.
Indications for fold transitions caused by alternative splicing
For 225 non-trivial isoforms (excluding repetitive and
conserved coil cases as these splice events will presumably
not result in a diﬀerent fold), we searched for similar
structures as described in the Materials and Methods
section. Applying the TM-Score criterion (TM-
Score>0.4) (19) alone we ﬁnd for 139 (66%) isoform
structures resulting from splicing events a similar structure
from a diﬀerent fold. Applying the more stringent
criterion (secondary structure and isoform coverage)
results in 49 isoforms (47 of which have a TM-Score
>0.4). For these, we superposed the spliced structure with
the target fold and visually inspected the superpositions
for conservation of core secondary-structure elements as
well as their connectivity, i.e. the topology of the core
elements. We observe 21 (10%) highly conﬁdent super-
positions, i.e. models for the spliced structures having a
fold diﬀerent from the fold of the non-spliced protein.
Thus, these diﬀerent folds are probable structural
models for the isoform, which could explain the drastic
changes caused by the splicing event (four examples are
shown and brieﬂy discussed in Figure 3 and may be
interactively explored at http://www.bio.iﬁ.lmu.de/
ProSAS/NARSupplement.html). Of course, proteins
resulting from splicing events might not be able to fold at
all into a stable structure and often this will be the case.
In other cases, the structure might be stable but will form a
novel fold (so far not solved and deposited in the PDB).
In rare cases, the modiﬁed structure might be similar to a
known fold diﬀerent from the native one. In the latter case,
we would observe links between diﬀerent folds by deﬁned
genetic changes (alternative splicing) transforming one
stable 3D structure into a diﬀerent stable 3D structure.
Despite many attempts and research on structure classiﬁ-
cations and structural descriptions and features, which led
to the well-known structural resources such as SCOP and
CATH (29), reliable and traceable links between fold
classes are very rare. This is even more the case for
evolutionary explanations of the observed similarities and
events. Here we do not only observe a considerable number
of such transformation events but with alternative splicing
also provide a simple genetic mechanism explaining them
as all the events correspond to known observed transcripts.
Validation of non-trivial splicing event using exon arraydata
Recently, Aﬀymetrix released a novel type of DNA-chip
which iscapable of measuring most exons in human (Homo
sapiens) as well as mouse (Mus musculus) and rat (Rattus
norvegicus) by single probesets on the chip. The analysis of
such chips allows measuring the expression of diﬀerent
transcripts of one gene in vivo, under diﬀerent experimental
conditions and in diﬀerent tissues. The time and tissue-
speciﬁc expression of certain transcripts may be another
indication of a functional role of the corresponding gene
product in the cell and will therefore help to understand
functional diversity resulting from alternative splicing.
Additionally, this data will be a helpful resource to validate
or falsify our hypothesis that many, in particular also
non-trivial splicing events may play functional roles in
the cell. For this reason we have mapped all probesets
provided on the human exon chip onto human
exons annotated in Ensembl (30). Additionally, we have
structurally modelled all human genes for which we
can ﬁnd reliable structural annotations in the PDB.
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at: http://services.bio.iﬁ.lmu.de/ProSAS. In total, we are
able to cover 80.1% of all human exons with at least one
Aﬀymetrix probeset. When concentrating on high-quality
structures (more than 40% sequence identity between
template and human transcript) 35% of the human genes
are covered at least partly by protein structure while 17%
are completely (more than 75% coverage) modelled by a
protein structure. This indicates that the combination of
exon chip experiments with structural data indeed has the
potential to test our hypothesis since a large number of
genes (and exons) is at the same time covered by structure
and measured on the chip.
DISCUSSION
Our study reveals a large number of functionally
important, alternatively spliced proteins that harbour
non-trivial splicing events and hints to a high degree of
plasticity and a large tolerance against major rearrange-
ments on the protein structure level. The possibility to
express the antagonist of a protein as an isoform of the
native variant represents an intuitive mechanism to
increase the functional complexity of an organism by
alternative splicing and has been discussed by several
studies before. The structural explanation for this
mechanism may be grounded in the removal of highly
conserved parts, which are essential for the function of the
native variant. If the isoform is still able to fold into a
native-like structure, it can mimic native structural
features and interact with native interaction partners
without processing them further. Thus, alternative splicing
immediately provides a mechanism for turning an
activator into an eﬀective inhibitor via a simple, possibly
regulated, genetic mechanism.
The sequence–structure protein space tries to link
diﬀerent folds by appropriate similarities and diﬀerences
but examples for fold transitions are rare and typically
diﬃcult to explain biologically. Our study provides
examples for such links and explains them with a simple
and common genetic mechanism. Thus, alternative spli-
cing may be a new approach to chart the protein space and
gain insights into mechanism of protein structure evolu-
tion. Future work will be on exploring the fold space as
well as the changes that occur within and between folds in
the context of alternative splicing in more detail.
Therefore, structural analysis of alternative splicing
events may help to identify common paths of protein
fold evolution similar to the events discussed by (12) and
to describe events that may be tolerated within protein
families. This knowledge may have interesting applica-
tions in protein design.
Without experimental proof we can currently only
speculate about the structures of isoforms resulting from
non-trivial splicing events. Several facts indicate that at
least some of those isoforms could have a well-deﬁned
structure. They perform a well-deﬁned function in the
cell and are able to mimic features of their native
counterparts. Additionally, the identiﬁcation of fold
transitions exempliﬁes that they could adopt structures
from diﬀerent folds. Nevertheless, they might also be
unstructured or fold into yet unknown conformations.
Therefore, this study will provide interesting starting
points for experimentalists trying to gain a deeper
understanding of the non-trivial alterations of protein
structure produced by alternative splicing and will lead to
new insights into protein structure stability and the
principles of protein fold evolution.
We also expect recently established experimental
techniques like exon-level microarrays to contribute
signiﬁcantly to our understanding of the functional and,
in the context of this study more important, the structural
eﬀects of alternative splicing. NMR-techniques (32) and
mass spectrometry (33) measuring complete proteomes
will contribute to validate or falsify the importance of
alternative splicing for the functional diversity of complex
organisms.
As, in principle, alternative splicing is a mechanism to
produce a combinatorial number of transcripts, even a
small percentage of stable structures implies a very large
number of new protein variants. Thus, we believe that
evolution makes use of alternative splicing to produce
structural and functional diversity and this diversity is
due to the large structural plasticity of proteins. Under-
standing alternative splicing on the proteome level will be
one of the major challenges of computational and
experimental biology in the next years.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
Additional supplementary data, especially an interactive
version of ﬁgure 3 which supports our argumentation is
available at the following page: http://www.bio.iﬁ.lmu.de/
ProSAS/NARSupplement.html
ACKNOWLEDGEMENTS
Funding to pay the Open Access publication charges
for this article was provided by the Ludwig-Maximilians-
Universita ¨ t (LMU) Mu ¨ nchen.
Conﬂict of interest statement. None declared.
REFERENCES
1. Johnson,J.M., Castle,J., Garrett-Engele,P., Kan,Z., Loerch,P.M.,
Armour,C.D., Santos,R., Schadt,E.E., Stoughton,R. et al. (2003)
Genome-wide survey of human alternative pre-mRNA splicing
with exon junction microarrays. Science, 302, 2141–2144.
2. Schwerk,C. and Schulze-Osthoﬀ,K. (2005) Regulation of
apoptosis by alternative pre-mRNA splicing. Mol. Cell, 19, 1–13.
3. Lipscombe,D. (2005) Neuronal proteins custom designed by
alternative splicing. Curr. Opin. Neurobiol., 15, 358–363.
4. Venables,J.P. (2004) Aberrant and alternative splicing in cancer.
Cancer Res., 64, 7647–7654.
5. Stetefeld,J. and Ruegg,M.A. (2005) Structural and functional
diversity generated by alternative mRNA splicing. Trends Biochem.
Sci., 30, 515–521.
6. Berman,H., Henrick,K., Nakamura,H. and Markley,J.L. (2007)
The worldwide Protein Data Bank (wwPDB): ensuring a single,
uniform archive of PDB data. Nucleic Acids Res., 35, D301–D303.
Nucleic Acids Research,2008, Vol. 36,No. 2 5577. Garcia,J., Gerber,S.H., Sugita,S., Sudhof,T.C. and Rizo,J. (2004)
A conformational switch in the Piccolo C2A domain regulated by
alternative splicing. Nat. Struct. Mol. Biol., 11, 45–53.
8. Romero,P.R., Zaidi,S., Fang,Y.Y., Uversky,V.N., Radivojac,P.,
Oldﬁeld,C.J., Cortese,M.S., Sickmeier,M., LeGall,T. et al. (2006)
Alternative splicing in concert with protein intrinsic disorder
enables increased functional diversity in multicellular organisms.
Proc. Natl Acad. Sci. USA, 103, 8390–8395.
9. Tress,M.L., Martelli,P.L., Frankish,A., Reeves,G.A., Wesselink,J.J.,
Yeats,C., Olason,P.L., Albrecht,M., Hegyi,H. et al. (2007) The
implications of alternative splicing in the ENCODE protein
complement. Proc. Natl Acad. Sci. USA, 104, 5495–5500.
10. Wang,P., Yan,B., Guo,J.T., Hicks,C. and Xu,Y. (2005) Structural
genomics analysis of alternative splicing and application to isoform
structure modeling. Proc. Natl Acad. Sci. USA, 102, 18920–18925.
11. Wu,C.H., Apweiler,R., Bairoch,A., Natale,D.A., Barker,W.C.,
Boeckmann,B., Ferro,S., Gasteiger,E., Huang,H. et al. (2006)
The Universal Protein Resource (UniProt): an expanding universe
of protein information. Nucleic Acids Res., 34, D187–D191.
12. Grishin,N.V. (2001) Fold change in evolution of protein structures.
J. Struct. Biol., 134, 167–185.
13. Altschul,S.F., Madden,T.L., Schaﬀer,A.A., Zhang,J., Zhang,Z.,
Miller,W. and Lipman,D.J. (1997) Gapped BLAST and
PSI-BLAST: a new generation of protein database search programs.
Nucleic Acids Res., 25, 3389–3402.
14. Needleman,S.B. and Wunsch,C.D. (1970) A general method
applicable to the search for similarities in the amino acid
sequence of two proteins. J. Mol. Biol., 48, 443–453.
15. Andreeva,A., Howorth,D., Brenner,S.E., Hubbard,T.J., Chothia,C.
and Murzin,A.G. (2004) SCOP database in 2004: reﬁnements
integrate structure and sequence family data. Nucleic Acids Res., 32,
D226–D229.
16. Birzele,F., Gewehr,J.E., Csaba,G. and Zimmer,R. (2007)
Vorolign – fast structural alignment using Voronoi contacts.
Bioinformatics, 23, e205–e211.
17. Shatsky,M., Nussinov,R. and Wolfson,H.J. (2006) Optimization
of multiple-sequence alignment based on multiple-structure align-
ment. Proteins, 62, 209–217.
18. Zhang,Y. and Skolnick,J. (2004) Scoring function for automated
assessment of protein structure template quality. Proteins, 57,
702–710.
19. Zhang,Y. and Skolnick,J. (2004) Automated structure prediction
of weakly homologous proteins on a genomic scale. Proc. Natl
Acad. Sci. USA, 101, 7594–7599.
20. Sudo,T., Yagasaki,Y., Hama,H., Watanabe,N. and Osada,H. (2002)
Exip, a new alternative splicing variant of p38 alpha, can induce an
earlier onset of apoptosis in HeLa cells. Biochem. Biophys. Res.
Commun., 291, 838–843.
21. Tailor,P., Gilman,J., Williams,S. and Mustelin,T. (1999) A
novel isoform of the low molecular weight phosphotyrosine
phosphatase, LMPTP-C, arising from alternative mRNA splicing.
Eur. J. Biochem./FEBS, 262, 277–282.
22. Ruben,S.M., Narayanan,R., Klement,J.F., Chen,C.H. and
Rosen,C.A. (1992) Functional characterization of the NF-kappa
B p65 transcriptional activator and an alternatively spliced
derivative. Mol. Cell. Biol., 12, 444–454.
23. Whitman,S., Wang,X., Shalaby,R. and Shtivelman,E. (2000)
Alternatively spliced products CC3 and TC3 have opposing
eﬀects on apoptosis. Mol. Cell. Biol., 20, 583–593.
24. Srinivasula,S.M., Ahmad,M., Guo,Y., Zhan,Y., Lazebnik,Y.,
Fernandes-Alnemri,T. and Alnemri,E.S. (1999)
Identiﬁcation of an endogenous dominant-negative short
isoform of caspase-9 that can regulate apoptosis. Cancer Res., 59,
999–1002.
25. Andrade,M.A., Perez-Iratxeta,C. and Ponting,C.P. (2001) Protein
repeats: structures, functions, and evolution. J. Struct. Biol., 134,
117–131.
26. Lang,D., Thoma,R., Henn-Sax,M., Sterner,R. and Wilmanns,M.
(2000) Structural evidence for evolution of the beta/alpha barrel
scaﬀold by gene duplication and fusion. Science, 289, 1546–1550.
27. Miles,E.W. and Davies,D.R. (2000) Protein evolution. On the
ancestry of barrels. Science, 289, 1490.
28. Saito,A., Ozaki,K., Fujiwara,T., Nakamura,Y. and Tanigami,A.
(1999) Isolation and mapping of a human lung-speciﬁc gene,
TSA1902, encoding a novel chitinase family member. Gene, 239,
325–331.
29. Pearl,F., Todd,A., Sillitoe,I., Dibley,M., Redfern,O., Lewis,T.,
Bennett,C., Marsden,R., Grant,A. et al. (2005) The CATH
Domain Structure Database and related resources Gene3D and
DHS provide comprehensive domain family information for
genome analysis. Nucleic Acids Res., 33, D247–D251.
30. Hubbard,T.J., Aken,B.L., Beal,K., Ballester,B., Caccamo,M.,
Chen,Y., Clarke,L., Coates,G., Cunningham,F. et al. (2007)
Ensembl 2007. Nucleic Acids Res., 35, D610–D617.
31. Birzele,F., Ku ¨ ﬀner,R., Meier,F., Oeﬁnger,F., Potthast,C. and
Zimmer,R. (2007) ProSAS: a database for analyzing alternative
splicing in the context of protein structures. Nucleic Acids Res.,
doi:10.1093/nar/gkm793.
32. Filipp,F.V. and Sattler,M. (2007) Conformational plasticity of the
lipid transfer protein SCP2. Biochemistry, 46, 7980–7991.
33. Adachi,J., Kumar,C., Zhang,Y. and Mann,M. (2007) In-depth
Analysis of the Adipocyte Proteome by Mass Spectrometry and
Bioinformatics. Mol. Cell Proteomics, 6, 1257–1273.
34. Michalopoulos,I., Torrance,G.M., Gilbert,D.R. and Westhead,D.R.
(2004) TOPS: an enhanced database of protein structural topology.
Nucleic Acids Res., 32, D251–D254.
35. Bloch,V., Yang,Y., Margeat,E., Chavanieu,A., Auge,M.T.,
Robert,B., Arold,S., Rimsky,S. and Kochoyan,M. (2003) The
H-NS dimerization domain deﬁnes a new fold contributing to DNA
recognition. Nat. Struct. Biol., 10, 212–218.
558 Nucleic Acids Research, 2008, Vol. 36, No. 2